Similar Articles
Alternative electric tumor treatment areas in glioblastoma multiforme treatment: Rationale, preclinical and clinical studies
Ayşe Uyanık, Yusuf Bahap, Alpcan Ateş, Elif Özge Doğan, Oytun Erbaş
DOI: 10.5606/fng.btd.2017.027
Issue: 2017, Volume 3 - Issue 4
0
3731
Current trends in Glioblastoma
Mihrican Koçak, Özüm Atasoy, Nilsu Çini, Oytun Erbaş
DOI: 10.5606/fng.btd.2021.25074
Issue: 2021, Volume 7 - Issue 3
5340
1626
Glioblastoma multiforme: Subtypes based on IDH, ATRX, H3F3A, MGMT and p53 mutations
Fatime Akgeyik, Alper Demirezen, Oytun Erbaş
DOI: 10.5606/fng.btd.2024.144
Issue: 2024, Volume 10 - Issue 1
4784
1735
Genetically engineered mice models and generating glioblastoma multiforme in the brain
Yasin Polat, Oytun Erbaş
DOI: 10.5606/fng.btd.2024.147
Issue: 2024, Volume 10 - Issue 1
2860
1947
Balancing Act: NRF2's contradictory roles in cancer progression and therapy
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/fng.btd.2024.160
Issue: 2024, Volume 10 - Issue 3
6252
1233